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science. They want to be excited, to
be wowed by the applications and by
the discussions that they
engender — that is their intellectual
payoff for the hard work and angst
engendered by study section service.
Reviewers do not begin by looking
for reasons to denigrate an
application; they look for substance,
for reasons to say, ‘this work must be
done — if successful it will surely
have a great impact.’ Much is said
about the conservatism of study
sections but in my experience this is
mainly a reflection of the
conservatism of applicants.
Most applications are
distressingly similar. The organisms
or systems may change but the
questions and approaches barely
differ. A novel application, well
argued, stands out like a bright
beacon and is rewarded by study
section members.
There is another important
factor that motivates study section
members to be fair. Participating
in the meeting are some of the
influential practitioners in their
field who know who is competing
and who is collaborating. These
are colleagues whose respect it is
imperative study section members
maintain. The upshot is that
reviewers give their competitors
the benefit of the doubt and
collaborators are held to a very
high standard. Few wish to look
the fool by seeming to be self-
serving or gullible.
The NIH peer review system
is not perfect, nor do I believe that it
is perfectible since it depends to
such a high degree on the
personalities and talents of people. It
is, as many have said, the best
system we have for distributing the
largesse provided by the public. It
works best when all participants
recognize that it is a human endeavor
with all the strengths and
weaknesses that that entails.
Gerald Greenhouse is Director of
Administration, Department of Cell Biology,
Harvard Medical School, C517, Boston,
Massachusetts 02115, USA.
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In mitosis and meiosis, unattached
kinetochores are sources for signaling
the spindle checkpoint which
inhibits precocious sister chromatid
separation and prevents aneuploidy
(reviewed in [1]). The 3F3/2 anti-
phosphoepitope antibody recognizes
a phosphoepitope present on
unattached kinetochores that is
sensitive to mechanical tension
imparted by microtubule binding
[2–4]. Intracellular injection of this
antibody artificially preserves the
phosphoepitope at kinetochores,
even after microtubule attachment,
and delays the onset of anaphase [5].
The anaphase-promoting
complex/cyclosome (APC/C) is an
E3/ubiquitin ligase required for
anaphase onset. The activation
and/or targeting of the APC/C is
regulated by the spindle checkpoint.
Activity of the APC/C is influenced
by its phosphorylation, and by its
association with inhibitory and/or
activating proteins (reviewed in
[6–8]). Here, we show that the 3F3/2
anti-phosphoepitope antibody binds
two mitotically phosphorylated
components of the APC/C.
Extracts from mammalian cells,
arrested in S phase with
hydroxyurea or in mitosis with
microtubule inhibitors, were
immunoprecipitated with anti-
Cdc27 antibody and 3F3/2 antibody.
As previously shown, anti-Cdc27
antibody immunoprecipitates the
APC/C complex from both
interphase and mitotic cell extracts
(Figure 1a) [9]. In mitotic extracts
both Cdc27 and Cdc16 protein
exhibited reduced mobilities
(Figure 1a, lane 8). Treatment of the
mitotic APC/C with phosphatase
increased the mobilities to those of
the S-phase extract (Figure 1a,
lane 11) indicating that the reduced
mobilities of mitotic Cdc27 and
Cdc16 are likely to be due to
M-phase-specific phosphorylation.
The 3F3/2 antibody quantitatively
immunoprecipitated mitotic APC/C
proteins and immunoprecipitated
associated M-phase specific
regulatory proteins Cdc20 and Mad2
(Figure 1a (lanes 14 and 15) and b).
The 3F3/2 antibody preferentially
precipitated the reduced-mobility
(phosphorylated) forms of APC/C
components. The 3F3/2 antibody
did not immunoprecipitate the
APC/C from S-phase extract
(Figure 1a, lanes 6 and 7). Thus the
3F3/2 antibody recognizes M-phase-
specific phosphorylations on one or
more components of the APC/C. 
Western blotting of mitotic
APC/C with the 3F3/2 antibody
revealed no bands (data not shown)
suggesting that the phosphoepitope
recognized by the 3F3/2 antibody
was denatured or destroyed during
SDS–gel electrophoresis and
electroblotting. To identify
prospective targets of the 3F3/2
within the APC/C, we first
immunoprecipitated the APC/C from
mitotic cell extracts using anti-Cdc27
antibody and applied 3F3/2 antibody
that had been covalently modified by
binding the trifunctional crosslinking
reagent sulfosuccimimidyl
[2-6-(biotinamido)-2-(p-azido-
benzamido)-hexanoamido)ethyl-
1,3′dithio-proprionate (Sulfo-SBED,
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Pierce) to transfer biotin to the target
protein of the APC/C (Figure 2a; and
see Supplementary material). In
addition to the 3F3/2 antibody heavy
and light chains, only one specific
protein, of 210 kDa, was
biotinylated. This band was
identified as Apc1 (Figure 2b). In
another approach, mitotic cell
extracts were treated with an
intermediate concentration of SDS
(0.5%) to disrupt the APC/C
(Figure 2c) and then immuno-
precipitated with 3F3/2 antibody. We
found that Apc1 and Cdc27 were
independently immunoprecipitated
by 3F3/2 antibody (Figure 2d). 
Jorgensen et al. [10] showed that
Apc1 was concentrated at
kinetochores of mitotic cells and, in
some murine lines, was retained at
centromeres throughout the cell
cycle. While early immuno-
localization evidence suggested that
Cdc27 was present along spindle
fibers and spindle poles [9], more
specialized immunolabeling methods
(for example, microinjection of
antibodies) reveals that Cdc27 is also
present on chromosomes and
concentrated at kinetochores
(L.M.T. and G.J.G., unpublished
observations). In addition, both
Tsg24 and Cdc27 are detected in
western blots of isolated mammalian
chromosomes ([10]; L.M.T. and
G.J.G., unpublished observations).
Although not yet proven, we
hypothesize that the changes of 3F3/2
phosphoepitope labeling at
kinetochores may reflect, at least in
part, changes in phosphorylation of
the APC/C components present there.
On the basis of the observed dynamic
association of other checkpoint
proteins and changes in kinetochore
phosphorylation, we and others have
proposed that the kinetochore is a
catalytic site for the generation of an
inhibitor of the APC/C [11–13]. One
element in downregulating APC/C
activity is inhibitory phosphorylation
of APC/C components [14,15]. Studies
by Waters et al. [16] have
demonstrated that Mad2, the inhibitor
of Cdc20-directed APC/C activity,
binds only to mitotic kinetochores that
are phosphorylated and exhibit the
3F3/2 phosphoepitope. We speculate
that at unattached kinetochores, active
kinases may catalyze phosphorylations
that directly inhibit APC/C activity or
indirectly inhibit by enhancing the
binding of Mad2 to the APC/C.
Further elucidation of the controls for
APC/C ubiquitin ligase activity and
the mechanisms by which the APC/C
targets specific substrates will provide
important new insights into cell-cycle
regulation of M phase.
Supplementary material
Supplementary material including detailed
methods and supplementary discussion is
available at http://current-biology.com/supmat/
supmatin.htm.
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Figure 1
The 3F3/2 anti-phosphoepitope antibody
immunoprecipitates mitotic APC/C.
(a) Whole-cell extracts were prepared from
HeLa cells arrested in S phase (lane 1) or M
phase (lane 8) and blotted with antibody to
Cdc27 (upper panel) and Cdc16 (lower
panel). Anti-Cdc27, Anti-HA (control
monoclonal), rabbit preimmune, and 3F3/2
antibodies were used to immunoprecipitate S
phase (lanes 2–7) and M phase (lanes 9–15)
extracts. The immunoprecipitated material
(IP) and the supernatants (S) were then
blotted with anti-Cdc27 and anti-Cdc16
antibodies. Anti-Cdc27 immunoprecipitates
from extracts of cells arrested in S phase or
M phase contained both Cdc27 and Cdc16.
Cdc27 and Cdc16 from mitotic extracts had
reduced electrophoretic mobility compared
to the same proteins from S-phase cell
extracts. Treatment of anti-Cdc27
immunoprecipitate from mitotic extract with
lambda phosphatase (IP, lane 11) increased
the mobilities of Cdc27and Cdc16,
indicating that the reduced mobilities of
mitotic Cdc27 and Cdc16 were due to
phosphorylation. The 3F3/2 anti-
phosphoepitope antibody precipitated
Cdc27 and Cdc16 only from mitotic cell
extracts. (b) Suspension HeLa cell cultures
blocked in M phase with microtubule
inhibitors generally resulted in a mitotic index
of 70–90%. When the 3F3/2 antibody is
used for immunoprecipitation from extracts of
these cells, the reduced-mobility
(phosphorylated) forms of Apc1, Cdc27 and
Cdc16 were immunoprecipitated, whereas
the faster-migrating forms (non-
phosphorylated and presumably from non-
mitotic cells) were not. The 3F3/2 antibody
also precipitated the Cdc20 and Mad2
proteins that associate with the APC/C only
during mitosis. 
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Figure 2
3F3/2 antibody recognizes phosphoepitopes on mitotic Apc1 and
Cdc27. (a) Protocol for antibody-mediated biotin transfer to the target
proteins with Sulfo-SBED reagent. (b) APC/C proteins were
immunopurified from mitotic cell extract with anti-Cdc27 antibody and
then treated with Sulfo-SBED-derivatized 3F3/2 antibody. A western
blot containing three lanes of product was cut down the center lane
and blotted with streptavidin–horse-radish peroxidase and anti-Apc1
antibody. The two probes identified the identical band (arrow). 
(c) Treatment of mitotic HeLa cell extracts with 0.5% SDS dissociates
Apc1 and Cdc27. Anti-Cdc27 immunoprecipitates both Apc1 and
Cdc27 in mock-treated extracts but only Cdc27 in mitotic extracts
treated with 0.5% SDS. (d) 3F3/2 independently immunoprecipitates
Apc1 and Cdc27. In mock-treated extracts, 3F3/2 antibody
immunoprecipitates a complex containing Apc1, Cdc27, Cdc16,
Cdc20 and Mad2. In SDS-treated extracts, 3F3/2 immunoprecipitates
Apc1 and Cdc27 but not the other proteins.
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